Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypes.

Circulation - 1 Jan 1992

Sentí M, Nogués X, Pedro-Botet J, Rubiés-Prat J, Vidal-Barraquer F

Abstract excerpt

BACKGROUND: The role of lipoprotein disturbances in the development of peripheral vascular disease (PVD) has not been sufficiently clarified. METHODS AND RESULTS: The relations among concentrations of intermediate density lipoproteins (IDL), apoprotein (apo) B, apo E, and other lipoproteins were studied in 102 men with PVD and 100 healthy men who formed the control group. Patients with PVD had significantly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lipids

Share to Lipoproteins

Share to Osmolar Concentration

Share to Phenotype

Share to Smoking

Source

Identifiers

PMID: 1728461
DOI: 10.1161/01.cir.85.1.30

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Lipoprotein profile in men with peripheral vascular disease. Role of intermediate density lipoproteins and apoprotein E phenotypes.PMID 1728461Read ↗

Apolipoprotein(a) genetic polymorphism and serum lipoprotein(a) concentration in patients with peripheral vascular disease.Semantic proximity Read ↗

Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease.Semantic proximity Read ↗

Thrombophilic risk factors for symptomatic peripheral arterial disease.Semantic proximity Read ↗

Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease.Semantic proximity Read ↗

Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism.Semantic proximity Read ↗

Apolipoprotein E polymorphism as a risk factor for vascular disease in diabetic patients.Semantic proximity Read ↗

Apolipoprotein E polymorphism and serum concentrations in patients with glycogen storage disease type Ia.Semantic proximity Read ↗

Influence of apolipoproteins on the anatomical distribution of arterial disease.Semantic proximity Read ↗

Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus.Semantic proximity Read ↗

The impact of the apolipoprotein E polymorphism on the lipoprotein profile in insulin-dependent diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study IX.Semantic proximity Read ↗

Apolipoprotein E polymorphism and the distribution profile of very low density lipoproteins; an influence of the E4 allele on large (Sf > 60) particles.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.